Debate – AI Use in ART: Is It Artificial or Intelligent?

Ilan Tur-Kaspa; Ravi Gada, MD; Charlie Bormann, PhD, HCLD

Read About llan
Read About Ravi
Read About Charlie
Thursday, March 21
1:45 PM – 2:30 PM


 Session Description
  • Repro-AI is defined as the interdisciplinary technology between reproductive medicine and mathematical sciences to advance the applications of AI in the diagnosis and treatment of infertility. AI may be implemented at the REI clinic as well as at the IVF and Andrology Labs. The advantages of AI fast big data analysis are simultaneous objective, accurate, and rapid assessment of relevant variables which leads to precision, standardization, and automation. While minimal training is needed, AI may provide guidance in clinical decisions, from evidence-based patient education resources to assisting in individualized FSH starting dose for IVF and prediction of oocyte yield per cycle and the probability of live births per specific cycle and/or number of fresh or frozen oocytes. The optimal day of the trigger during COS for IVF may be optimized by AI image analysis of ultrasound pictures and hormone levels. AI image analysis of sperm, oocytes, and embryos may change the way we choose sperm to fertilize an egg and how we choose an embryo for transfer. AI may even become a non-invasive PGT tool. Is AI to assist or take control in the decision-making process? What if the AI and the clinician or embryologist disagree? AI in ART is currently being developed as an assistive technology and ethical and patient privacy considerations should be considered. With recent developments, AI for ART is here to stay.

Session Objective
  1.  Demonstrate knowledge of AI potential use in Reproductive Medicine.

  2. Manage ART patients with AI assisted decision making tools.

  3. Integrate AI tools in clinic and and IVF Lab specific practices to improve ART outcome.